Asst. Prof. Dr. Özlem Apti Şengkioun
Dermatology
About Özlem Apti Şengkioun
Assist. Prof. Özlem Apti Şengkioun is a board-trained dermatologist with specialized training from Marmara University Faculty of Medicine, where she completed her Dermatology and Venereology education in 2022. She currently practices with Acıbadem Health Group, bringing evidence-based care and a patient-centered approach to medical and cosmetic dermatology. An active member of the professional community, she holds memberships in the European Academy of Dermatology and Venereology, the Turkish Dermatology Association, and the Skin and Venereal Diseases Association. Her clinical interests include inflammatory skin disorders, dermatologic surgery, and the integration of new therapies and technologies to improve patient outcomes. Known for clear communication and compassionate care, Assist. Prof. Özlem emphasizes individualized treatment plans and continuing professional development to stay current with advances in dermatology.
Subspecialties
- Atopic dermatitis
- Moderate-to-severe atopic dermatitis
- Psoriasis
- Livedoid vasculopathy
- Chronic spontaneous urticaria
- Yellow urticaria
- Netherton syndrome
- Isothiazolinone contact allergy
- Nailfold capillaroscopy
- Dermatologic surgery
Education
- 2022 Marmara University Faculty of Medicine Dermatology and Venereology
- 2017 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2024 Acibadem Health Group
- 2023 Acibadem Health Group
- 2018 – 2022 Marmara University Faculty of Medicine / Department of Skin and Venereal Diseases /
Professional Memberships
- European Academy of Dermatology and Venereology
- Turkish Dermatology Association
- Skin and Venereal Diseases Association
Selected Publications
- A review of comorbidities of Atopic dermatitis Indian Journal of Skin Allergy doi: 10.25259/IJSA_37_2024 July 24 Apti Sengkioun, O., Salman A.
- Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy Microvasc Res. 2023 Aug 4;150:104591. doi: 10.1016/j.mvr.2023.104591. Epub ahead of print. PMID: 37543163. Apti Sengun O, Ergun T, Guctekin T, Alibaz Oner F.
- Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study Vaccine. 2023 Jun 29;41(29):4287-4294. doi: 10.1016/j.vaccine.2023.05.052. Epub 2023 Jun 3. PMID: 37277251; PMCID: PMC10239265. Ergun T, Hosgoren Tekin S, Apti Sengun O, Akin Cakici O, Seckin D, Adiay C, Enul H, Yilmaz S, Ay P, Haklar G, Sili U.
- Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis. Dermatol Ther. 2022 Jan;35(1):e15192. doi: 10.1111/dth.15192. Epub 2021 Nov 15. PMID: 34743366 Salman A, Apti Sengun Ö, Aktas M, Taskapan O.
- Evaluation of capillaroscopic findings and endothelial dysfunction in patients withivedoid vasculopathy. Tıpta Uzmanlık Tezi, 2022, İstanbul Apti Sengun, Ozlem.
- Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data. Australas J Dermatol. 2021 Aug;62(3):398-402. doi: 10.1111/ajd.13656. Epub 2021 Jun 22. PMID: 34156714. Salman A, Aktas M, Apti Sengun O.
- Yellow Urticaria. The Journal of Allergy and Clinical Immunology In Practice, 9(1), 479?480. doi:10.1016/j.jaip.2020.10.029 Çakıcı, Ö. A., Sengün, O. A., Tekin, S. H., & Salman, A.
- Netherton syndrome: Temporary response to dupilumab. . Pediatr Dermatol. 2020 Nov;37(6):1210-1211. doi: 10.1111/pde.14362. Epub 2020 Sep 19. PMID: 32951242. Aktas M, Salman A, Apti Sengun O, Comert Ozer E, Hosgoren Tekin S, Akin Cakici O, Demir G, Ergun T.
- Slime A trending cause of isothiazolinone contact allergy in children Contact Dermatitis. doi:10.1111/cod.13237 Salman, A., Demir, G., & Apti, O.
Schedule your appointment with Asst. Prof. Dr. Özlem Apti Şengkioun
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.